Product Description
• Research indicates that patients of advanced maternal age have a lower cumulative pregnancy rate; namely, because of declining oocyte quality and a higher prevalence of oocyte senescence.
• Embryos produced from these oocytes have different metabolic needs and may require a modified environment to reach their optimal developmental potential.
• global® 35+TM is the first media designed to meet the metabolic requirements of embryos obtained from patients over the age of 35, with a poor prognosis or with repeat cycles.
• Pre-supplemented with protein to promote embryonic development and growth.